methyl 2-iodo-3-thiophenecarboxylate | 76360-44-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 噻吩类
• 英文名称: methyl 2-iodo-3-thiophenecarboxylate
• 英文别名: Methyl-2-iod-3-thiophencarboxylate；2-iodothiophene-3-carboxylic acid methyl ester；Methyl 2-iodothiophene-3-carboxylate
• CAS: 76360-44-6
• 化学式: C₆H₅IO₂S
• 分子量: 268.075
• InChiKey: LLMOWPNUVFHLEP-UHFFFAOYSA-N

物化性质

• 沸点：
  255.7±20.0 °C(Predicted)
• 密度：
  1.930±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  10
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  54.5
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  methyl 2-iodo-3-thiophenecarboxylate 在 四(三苯基膦)钯 铁粉 、 溶剂黄146 作用下， 以 四氢呋喃 、 乙二醇二甲醚 、 水 为溶剂， 反应 11.25h， 生成 4-oxo-4,5-dihydrothieno<3,2-c>quinoline
  参考文献：
  名称：

  Goerlitzer; Gabriel; Jomaa, Pharmazie, 2006, vol. 61, # 4, p. 278 - 284

  摘要：

  DOI：
• 作为产物：
  描述：

  3-噻吩甲酸 在 正丁基锂 、 硫酸 、 N,N-二异丙基乙胺 、 lithium diisopropyl amide 作用下， 以 四氢呋喃 为溶剂， 反应 15.33h， 生成 methyl 2-iodo-3-thiophenecarboxylate
  参考文献：
  名称：

  JP2022026650A

  摘要：

  公开号：

文献信息

• Retinoic acid X-receptor ligands
  申请人：Hoffmann-La Roche Inc.

  公开号：US05801253A1

  公开（公告）日：1998-09-01

  Compounds of formula (I) wherein R.sup.1 -R.sup.7, R.sup.10, X and the dotted bond have the meaning given in the specification, bind selectively to retinoid RXR receptors and are useful as antiproliferative agents for dermatological and oncological indications.

  式（I）中的化合物，其中R.sup.1 -R.sup.7，R.sup.10，X和点线键具有规范中给定的含义，可选择性地结合到视黄醇RXR受体，并可用作皮肤病和肿瘤学适应症的抗增殖剂。
• Novel compounds having 4-pyridylalkylthio group as substituent
  申请人：Honda Takahiro

  公开号：US20060194836A1

  公开（公告）日：2006-08-31

  A subject of the present invention is to provide a novel aromatic five- or six-memberd heterocyclic derivative having 4-pyridylalkylthio as a substituent or a salt thereof which is useful as a pharmaceutical. Compound represented by the following general formula [I] or salts thereof are useful as therapeutic agents for diseases in which angiogenesis or augmentation of vascular permeability is involved. In the formula, ring “A” is a benzene ring or an aromatic five- or six-memberd heterocycle which can be fused with a cycloalkane ring, “B” is alkylene, R 1 and R 2 , the same or different, are H, OH, substituted or unsubstituted alkoxy and the like, X and Y, the same or different, are group(s) selected from H, halogen, OH, substituted or unsubstituted alkoxy and the like respectively, p is 0, 1 or 2, and q is 0 or 1.

  本发明的目的是提供一种新的芳香性五元或六元杂环衍生物，其具有4-吡啶基烷硫基取代基或其盐，可作为药物使用。以下通式[I]所表示的化合物或其盐可用作治疗涉及血管生成或增强血管渗透性的疾病的治疗剂。其中，环“A”是苯环或芳香性五元或六元杂环，可以与环状烷基环融合，“B”是烷基，R1和R2，相同或不同，是H、OH、取代或未取代的烷氧基等，X和Y，相同或不同，分别是选择自H、卤素、OH、取代或未取代的烷氧基等的基团，p为0、1或2，q为0或1。
• Compounds having a 4-pyridylalkylthio group as a substituent
  申请人：Honda Takahiro

  公开号：US20090286786A1

  公开（公告）日：2009-11-19

  A compound having the following formula [I] or a pharmaceutically acceptable salt thereof: wherein A is benzene or an aromatic five-membered heterocycle which optionally is fused with a cycloalkane ring; B is an alkylene; R 1 and R 2 are hydrogen, hydroxy, alkoxy, aryloxy, alkyl, cycloalkyl, aryl, heterocycle, amino, alkylamino, arylamino or acyl, or R 1 and R 2 join together to form a heterocycle; X and Y are hydrogen, halogen, hydroxy, alkoxy, aryloxy, alkyl, cycloalkyl, aryl, mercapto, alkylthio, arylthio, carboxyl, an ester of carboxyl, an amide of carboxyl, cyano or nitro; p is 0, 1 or 2; and q is 0 or 1. The compound is useful for treating diseases in which angiogenesis or augmentation of vascular permeability is involved.

  一种具有以下式[I]或其药学上可接受的盐的化合物：其中，A是苯或一种芳香五元杂环，该芳香五元杂环可以选择性地与环烷环融合；B是一种烷基；R1和R2是氢、羟基、烷氧基、芳基氧基、烷基、环烷基、芳基、杂环、氨基、烷基氨基、芳基氨基或酰基，或R1和R2结合形成一个杂环；X和Y是氢、卤素、羟基、烷氧基、芳基氧基、烷基、环烷基、芳基、巯基、烷硫基、芳硫基、羧基、羧酸酯、羧酰胺、氰基或硝基；p为0、1或2；q为0或1。该化合物用于治疗与血管生成或血管通透性增加有关的疾病。
• COMPOUNDS HAVING 4-PYRIDYLALKYLTHIO GROUP AS A SUBSTITUENT
  申请人：Honda Takahiro

  公开号：US20120202817A1

  公开（公告）日：2012-08-09

  A compound having the following formula [I] or a pharmaceutically acceptable salt thereof: wherein A is an aromatic five-membered heterocycle which optionally is fused with a cycloalkane ring; B is an alkylene; R 1 and R 2 are hydrogen, hydroxyl, alkoxy, aryloxy, alkyl, cycloalkyl, aryl, heterocycle, amino, alkylamino, arylamino or acyl, or R 1 and R 2 join together to form a heterocycle; X and Y are hydrogen, halogen, hydroxyl, alkoxy, aryloxy, alkyl, cycloalkyl, aryl, mercapto, alkylthio, arylthio, carboxyl, an ester of carboxyl, an amide of carboxyl, cyano or nitro; p is 0, 1 or 2; and q is 0 or 1. The compound is useful for treating diseases in which angiogenesis or augmentation of vascular permeability is involved.

  以下化合物式[I]或其药学上可接受的盐：其中A是一种芳香五元杂环，可选择与环烷基融合；B是一种烷基；R1和R2是氢、羟基、烷氧基、芳氧基、烷基、环烷基、芳基、杂环、氨基、烷基氨基、芳基氨基或酰基，或R1和R2结合形成一个杂环；X和Y是氢、卤素、羟基、烷氧基、芳氧基、烷基、环烷基、芳基、巯基、烷硫基、芳硫基、羧基、羧酸酯、羧酰胺、氰基或硝基；p为0、1或2；q为0或1。该化合物可用于治疗涉及血管生成或增强血管通透性的疾病。
• Electrochemical 5-<i>exo-dig</i> aza-cyclization of 2-alkynylbenzamides toward 3-hydroxyisoindolinone derivatives
  作者：Zhaojiang Shi、Nan Li、Wei-Zhen Wang、Hao-Kuan Lu、Yaofeng Yuan、Zhen Li、Ke-Yin Ye

  DOI：10.1039/d2ob00637e

  日期：——

  Preparation of biologically relevant 3-hydroxyisoindolinones from readily available 2-alkynylbenzamides is an appealing synthetic approach. However, such kinds of compounds preferably undergo O-attacked 5-exo-dig/6-endo-dig cyclizations. Herein, we report an electrochemically generated amidyl radical proceeding via a highly selective N-attacked 5-exo-dig radical cyclization to form 3-hydroxyisoindolinone

  从容易获得的 2-炔基苯甲酰胺制备生物学相关的 3-羟基异吲哚酮是一种有吸引力的合成方法。然而，这类化合物优选经历O-攻击的5 -exo-dig /6 -endo-dig环化。在此，我们报道了一种电化学生成的酰胺基自由基，通过高选择性 N 攻击的 5 -exo-dig自由基环化形成 3-羟基异吲哚啉酮衍生物。该反应具有操作简单、选择性好、底物范围广等特点。此外，克级制备和合成工艺意味着该协议对合成各种异吲哚酮衍生物的潜在适用性。